The biosynthetic origin of pyripyropene A ii) was studied by feeding s
odium [1-C-13]-, [2-C-13]-, and [1,2-C-13(2)]acetates, D,L-[2-C-13]mev
alonolactone, and [carboxy-C-14]nicotinic acid to the producing organi
sm Aspergillus fumigatus FO-1289-2501. C-13 NMR and degradation experi
ments of C-13- and C-14-labeled 1 established that 1 is derived from t
hree mevalonates, five acetates, and one nicotinic acid. The biosynthe
tic scheme for 1 proposes that !1) a pyridino-alpha-pyrone moiety is p
roduced via condensation of a primer nicotinic acid with two acetates
in a ''head-to-tail'' fashion, (2) an all-trans farnesyl pyrophosphate
is produced via the mevalonate pathway, (3) the two parts are linked
and cyclized to form the core skeleton, and (4) then three acetyl resi
dues from acetates are introduced into the skeleton to yield 1. This i
s the first demonstration that an intact nicotinic acid works as an ac
yl primer unit for oligoketide formation in fungal secondary metabolit
es.